Trademark: 98340762
Word
PM PRIORITY MEDS
Status
Pending
Status Code
641
Status Date
Wednesday, August 7, 2024
Serial Number
98340762
Mark Type
3
Filing Date
Wednesday, January 3, 2024

Trademark Owner History

Classifications
44 Health care services, namely, providing health care and medical services by health care professionals via the Internet or telecommunication networks; Healthcare services, namely, providing telehealth, telemedicine, remote health care, virtual health care services; providing a website featuring health, medical, pharmaceutical and wellness information and advice; Consultancy services relating to health care
The mark consists of the letters "PM" surrounded by a shield with three horizontal lines to the left of the letter "P" all in the color blue. On the inside loop of the letter "P" is the depiction of a pill half solid blue and half solid red with a void separating the colors. The words "PRIORITY MEDS" are to the right of the shield with the word "PRIORITY" in red and "MEDS" in blue. There is a solid red cross overlayed on the middle part of the letter "E" in the word "MEDS". The word and image are set on a white background.
The color(s) red, white, and blue is/are claimed as a feature of the mark.
"MEDS"

Trademark Events
Jan 3, 2024
New Application Entered
Mar 11, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 22, 2024
New Application Office Supplied Data Entered
Mar 11, 2024
Teas Change Of Correspondence Received
Mar 11, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 22, 2024
Notice Of Design Search Code E-Mailed
Jul 30, 2024
Assigned To Examiner
Jul 31, 2024
Non-Final Action Written
Jul 31, 2024
Non-Final Action E-Mailed
Aug 1, 2024
Correspondence Received In Law Office
Aug 1, 2024
Teas/Email Correspondence Entered
Jul 31, 2024
Notification Of Non-Final Action E-Mailed
Aug 1, 2024
Teas Response To Office Action Received
Aug 7, 2024
Non-Final Action Written
Aug 7, 2024
Non-Final Action E-Mailed
Aug 7, 2024
Notification Of Non-Final Action E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24